Condition: Breast Cancer Stage I · Triple Negative Breast Cancer (TNBC) · Sponsor: The Netherlands Cancer Institute
The aim of this study is to investigate whether subjects with breast cancer that have certain favorable features, after performing the surgery and radiation, the chemotherapy can be safely omitted in the treatment. In addition, the investigation looks at whether the omission of chemotherapy ensures a better quality of life. Participants decide, in consultation with their treating physician, whether they choose to be treated with adjuvant chemotherapy or not.
This description comes directly from the study's public registry record.
Marleen Kok, MD · +31205129111 · m.kok@nki.nl
Rianne Rolfes, MD · +31205129111 · r.rolfes@nki.nl
Always discuss trial participation with your own doctor first.
| Zuyderland Medisch Centrum | Sittard-Geleen, Limburg, Netherlands | Not Yet Recruiting |
| Medical spectrum Twente | Enschede, Overijssel, Netherlands | Recruiting |
| Noordwest Ziekenhuisgroep | Alkmaar, Netherlands | Not Yet Recruiting |
| Flevoziekenhuis | Almere Stad, Netherlands | Not Yet Recruiting |
| Meander Medisch Centrum | Amersfoort, Netherlands | Recruiting |
| Antoni van Leeuwenhoek | Amsterdam, Netherlands | Recruiting |
| Onze Lieve Vrouwe Gasthuis (OLVG) | Amsterdam, Netherlands | Recruiting |
| Rijnstate | Arnhem, Netherlands | Recruiting |
| Amphia ziekenhuis | Breda, Netherlands | Recruiting |
| Deventer Ziekenhuis | Deventer, Netherlands | Recruiting |
| Ziekenhuis Gelderse Vallei | Ede, Netherlands | Recruiting |
| Catharina Ziekenhuis | Eindhoven, Netherlands | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06476119